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This article published in Pathology and Oncology Research, has
been retracted at the request of Editor-in-Chief and the authors
Hasibe Verdi, Yaprak Yilmaz-Yalcin, A. C. Yazici and Fatma-
Belgin Atac. The reasons for the retraction of the article are:
– There are substantial parts in the article that were previ-
ously published in the article: “Involvement of Toll-like
receptors in cervical cancer susceptibility among Tunisian
women” by Sabrina Zidi, Hasibe Verdi, Yaprak Yilmaz-
Yalcin, A.C. Yazici, Ezzedine Gazouani, Amel Mezlini,
Fatma-Belgin Atac, Besma Yacoubi-Loueslati, Bulletin
du Cancer, 2014; 101: E31-E35, DOI: 10.1684/bdc.2014.
2037. Although the article published in Pathology and
Oncology Research uses a larger control group the two
papers have very similar content, addressing the same
problem with the same methodology and the differences
in the articles were considered too minor.
– In addition, this article was submitted to Pathology and
Oncology Research without the knowledge or consent of
all the authors.
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